Source: StreetInsider

Press Release: Variantyx : Expanded STR Detection Capability Enables Variantyx to Diagnose Additional Genetic Disorders

FRAMINGHAM, Mass.--(BUSINESS WIRE)-- Variantyx, a leader in genomic precision medicine, today announced that the set of short tandem repeat (STR) expansions detected by its Genomic Unity® line of whole genome-based tests...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Haim Neerman's photo - Co-Founder & CEO of Variantyx

Co-Founder & CEO

Haim Neerman

CEO Approval Rating

88/100

Read more